Patients may have questions about their options for managing and treating Peyronie’s disease. According to most urological societies, providers are advised to inform patients of their options to the fullest extent possible. Meaning, informing patients about risks, benefits, and efficacy of each option available, whether they’re experimental or not. In order to inform patients to the fullest...
All SMSNA News
SMSNA News
SMSNA News
SMSNA Patients
SMSNA
SMSNA News
SMSNA
SMSNA News
SMSNA News
SMSNA Patients
SMSNA Patients
SMSNA Patients
SMSNA News